Total Payments
$14,149
2024 Payments
$26.76
Companies
26
Transactions
132
Medicare Patients
2,534
Medicare Billing
$182,173
Payment Breakdown by Category
Food & Beverage$14,046 (99.3%)
Education$103.32 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,046 | 120 | 99.3% |
| Education | $103.32 | 12 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,212 | 18 | $0 (2020) |
| Amarin Pharma Inc. | $1,881 | 24 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $1,700 | 14 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $1,174 | 11 | $0 (2020) |
| PFIZER INC. | $1,115 | 9 | $0 (2020) |
| Novo Nordisk Inc | $737.64 | 6 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $700.22 | 7 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $595.63 | 5 | $0 (2019) |
| Lilly USA, LLC | $449.82 | 4 | $0 (2020) |
| Allergan Inc. | $413.49 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26.76 | 1 | ABBVIE INC. ($26.76) |
| 2021 | $16.48 | 1 | AbbVie Inc. ($16.48) |
| 2020 | $1,357 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($375.00) |
| 2019 | $5,020 | 43 | Boehringer Ingelheim Pharmaceuticals, Inc. ($871.99) |
| 2018 | $3,487 | 33 | Amarin Pharma Inc. ($703.21) |
| 2017 | $4,242 | 43 | Amarin Pharma Inc. ($674.76) |
All Payment Transactions
132 individual payment records from CMS Open Payments — Page 5 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/18/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $116.67 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/12/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $100.00 | General |
| Category: Cardiovascular | ||||||
| 06/27/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $122.36 | General |
| Category: Hypertriglyceridemia | ||||||
| 06/27/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Education | In-kind items and services | $10.24 | General |
| Category: Hypertriglyceridemia | ||||||
| 06/22/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $115.48 | General |
| Category: Cardiovascular | ||||||
| 06/20/2017 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $114.64 | General |
| Category: Diabetes | ||||||
| 06/13/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Food and Beverage | In-kind items and services | $116.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/31/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $123.56 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/17/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $116.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/15/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $118.67 | General |
| Category: DIABETES | ||||||
| 05/11/2017 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $90.18 | General |
| Category: Diabetes | ||||||
| 05/04/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Food and Beverage | In-kind items and services | $111.65 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/18/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $124.38 | General |
| Category: Hypertriglyceridemia | ||||||
| 04/18/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Education | In-kind items and services | $10.24 | General |
| Category: Hypertriglyceridemia | ||||||
| 04/06/2017 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $90.20 | General |
| Category: Endocrinology | ||||||
| 04/04/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Cardiovascular | ||||||
| 03/29/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/23/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $123.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/23/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Education | Cash or cash equivalent | $6.25 | General |
| Category: Cardiovascular | ||||||
| 03/21/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Cardiovascular | ||||||
| 03/16/2017 | Mallinckrodt LLC | OFIRMEV (Drug) | Food and Beverage | In-kind items and services | $120.33 | General |
| Category: ACUTE CARE | ||||||
| 03/02/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $116.38 | General |
| Category: Hypertriglyceridemia | ||||||
| 03/02/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Education | In-kind items and services | $10.24 | General |
| Category: Hypertriglyceridemia | ||||||
| 03/02/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Education | In-kind items and services | $3.85 | General |
| Category: Hypertriglyceridemia | ||||||
| 02/22/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $124.72 | General |
| Category: Hypertriglyceridemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 587 | 1,072 | $61,131 | $43,815 |
| 2022 | 9 | 637 | 1,155 | $64,487 | $47,001 |
| 2021 | 9 | 619 | 1,098 | $59,772 | $44,424 |
| 2020 | 9 | 691 | 1,283 | $65,837 | $46,933 |
Total Patients
2,534
Total Services
4,608
Medicare Billing
$182,173
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 315 | $47,688 | $31,947 | 67.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 35 | 35 | $5,380 | $5,211 | 96.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 21 | $2,303 | $1,674 | 72.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 100 | 125 | $2,200 | $1,495 | 68.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 122 | 379 | $1,137 | $1,114 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 26 | 26 | $954.46 | $935.48 | 98.0% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 26 | 26 | $888.42 | $870.74 | 98.0% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 83 | 83 | $364.16 | $356.07 | 97.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 59 | 62 | $215.76 | $211.42 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 117 | 305 | $46,731 | $32,364 | 69.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 45 | 45 | $7,037 | $6,953 | 98.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 40 | $4,392 | $2,316 | 52.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 104 | 152 | $2,704 | $1,810 | 66.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 124 | 397 | $1,191 | $1,176 | 98.7% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 35 | 35 | $1,130 | $1,107 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 36 | 36 | $711.63 | $697.63 | 98.0% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 90 | 90 | $395.32 | $388.84 | 98.4% |
| 81002 | Urinalysis, manual test | Office | 2022 | 54 | 55 | $196.15 | $188.98 | 96.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 104 | 226 | $35,215 | $26,102 | 74.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 70 | 112 | $12,345 | $6,940 | 56.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 39 | 39 | $6,173 | $6,173 | 100.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 93 | 133 | $2,466 | $1,686 | 68.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 119 | 390 | $1,170 | $1,170 | 100.0% |
| 90756 | Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage | Office | 2021 | 38 | 38 | $1,078 | $1,078 | 100.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 38 | 38 | $774.44 | $774.44 | 100.0% |
About Dr. Luciano De Marco, M.D
Dr. Luciano De Marco, M.D is a Internal Medicine healthcare provider based in Valhalla, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1902940968.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Luciano De Marco, M.D has received a total of $14,149 in payments from pharmaceutical and medical device companies, with $26.76 received in 2024. These payments were reported across 132 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($14,046).
As a Medicare-enrolled provider, De Marco has provided services to 2,534 Medicare beneficiaries, totaling 4,608 services with total Medicare billing of $182,173. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Valhalla, NY
- Active Since 02/16/2007
- Last Updated 06/18/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1902940968
Products in Payments
- Vascepa (Drug) $1,881
- FARXIGA (Drug) $1,350
- ELIQUIS (Drug) $1,321
- JARDIANCE (Drug) $1,236
- Ozempic (Drug) $614.55
- INVOKANA (Drug) $592.91
- XARELTO (Drug) $581.24
- PRADAXA (Drug) $478.36
- Truvada (Drug) $373.72
- TRULICITY (Drug) $324.82
- Xofluza (Drug) $256.94
- XELJANZ (Drug) $247.48
- Trulance (Drug) $244.44
- ENTRESTO (Drug) $238.74
- STEGLATRO (Drug) $231.92
- BYDUREON (Drug) $224.99
- NAMZARIC (Drug) $149.99
- VRAYLAR (Drug) $135.47
- LINZESS (Drug) $128.03
- PRALUENT ALIROCUMAB INJECTION (Biological) $126.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Valhalla
Dr. Jay Doshi, M.d, M.D
Internal Medicine — Payments: $96,684
Internal Medicine $96,684
Neal Shah, M.d, M.D
Internal Medicine — Payments: $5,403
Internal Medicine $5,403
Sade Solola Nussbaum, Md, MD
Internal Medicine — Payments: $4,024
Internal Medicine $4,024
Rhonda Rubin, Md, MD
Internal Medicine — Payments: $2,982
Internal Medicine $2,982
Adrese Kandahari, M.d, M.D
Internal Medicine — Payments: $2,880
Internal Medicine $2,880
Rebecca Glassman, M.d, M.D
Internal Medicine — Payments: $2,793
Internal Medicine $2,793